U.S. Physical Therapy (NYSE:USPH) Releases Earnings Results, Beats Expectations By $0.04 EPS

U.S. Physical Therapy (NYSE:USPH) issued its earnings results on Wednesday. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04, Zacks reports. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. During the same period in the prior year, the business earned $0.66 EPS. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock traded up $4.92 during midday trading on Wednesday, reaching $89.66. The company had a trading volume of 282,843 shares, compared to its average volume of 166,089. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $90.94. The company has a market capitalization of $1.34 billion, a P/E ratio of 527.45, a P/E/G ratio of 2.15 and a beta of 1.16. The firm’s fifty day simple moving average is $83.40 and its 200-day simple moving average is $76.92.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, September 11th. Barrington Research raised their price objective on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $98.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.